Gene Munster Says It Won't Be A 'Wearables Holiday' For Meta, Analyst Says Company's AI On Display Glasses Crushed By ChatGPT In Side-By-Side Test

Deepwater Asset Management's Gene Munster reported a head-to-head test where Meta AI on Meta's new Display smart glasses understood ~90% of 50 identical prompts but produced satisfying answers only ~50% of the time, versus ChatGPT which understood 100% and delivered satisfactory responses 98% of the time. Munster nonetheless backs Meta's nearly $18 billion annual Reality Labs investment as AR/AI wearables are seen as a long-term platform; Meta recently launched $499 Oakley Meta Vanguard and $799 Ray-Ban Display glasses, and analysts' consensus price target sits at $826 (latest three average $776.67), implying roughly 22.55% upside.

Analysis

Market structure: Short-term winners are AI infrastructure and platform beneficiaries — MSFT (OpenAI/Azure exposure), NVDA (inference GPUs), and AAPL (premium AR lead times) — as consumers and enterprises gravitate to proven LLM UX. META is a near-term loser: Reality Labs’ $18B/year burn raises revenue-to-profitability timing risk and weakens pricing power for Meta’s wearables until user experience parity (likely 12–36 months) is achieved. Supply/demand: demand will skew toward high-performance inference chips and cloud capacity, tightening NVDA/MSFT exposure while consumer hardware demand for casual AR may lag, pressuring component vendors’ reorder rates over the next 2–4 quarters.

Risk assessment: Tail risks include regulatory actions (EU/US AI transparency or antitrust) and an Apple XR product launch (targeted 2027) that could materially slow Meta device adoption; a 20%+ slump in Reality Labs engagement within 12 months could trigger multi-billion impairment (>$20–30B). Timing: expect market repricing in days/weeks after major demos or earnings; structural adoption plays out over quarters/years. Hidden dependencies: Meta’s path depends on LLM quality, developer ecosystem, and ad-revenue cross-subsidy; failure in any layer magnifies cash burn.

Trade implications: Direct: establish overweight positions in MSFT and NVDA (2–4% each) to capture infrastructure demand; size a tactical underweight or hedge in META (1–2% short or buy puts). Pair: long MSFT, short META to play OpenAI/product-performance gulf; rebalance if spread narrows by 10%. Options: buy 6–12 month META puts (15–25% OTM) as low-cost tail hedge; consider buying NVDA 3–6 month calls on dips <5% with defined risk.

Contrarian angles: Markets may underweight Meta’s ability to subsidize long-term adoption — if Reality Labs shows sequential revenue growth >15% QoQ or engagement +20% year-over-year, re-rate risk becomes likely. The sell-off could be overdone if Meta leverages first-mover social graph advantages; historical parallel: Amazon AWS leveraged core assets to dominate cloud after skeptics. Unintended consequence: Apple entry could expand the TAM, benefiting infrastructure names even if it hurts Meta’s hardware share.

Key Decisions for Investors

• Establish a 2–4% long position in MSFT within 2 weeks to capture OpenAI/Azure exposure; trim if MSFT guidance for cloud revenue growth falls below 15% YoY on next two quarters.
• Allocate 2–4% long to NVDA on dips >3% as a 3–6 month tactical play for inference demand; take profits if NVDA rallies >30% from entry or if gross-margin guidance cuts by >200bps.
• Initiate a small asymmetric hedge on META: buy 6–12 month puts 15–25% OTM sized at 1–2% portfolio risk, or establish a 1–2% short position if liquidity allows; close if META rallies >15% in 30 days or Reality Labs revenue grows >15% QoQ.
• Execute a pair-trade: long MSFT (2%) and short META (1.5%) to exploit product-performance gap; re-evaluate in 90 days or after META’s next earnings — unwind if spread narrows by >10% absolute.
• Increase sector weight to AI infrastructure (semis/cloud) by +3% funded by reducing consumer AR/hardware exposure; reassess after Apple XR announcements (monitor WWDC/rumor cadence through 2026–2027) and after two consecutive quarters of Reality Labs KPI improvement (revenue or MAU +15%).